49 results
management infections hivaids prevention idsa diagnosis nephrology syndrome causes criticalcare medications neurology pathophysiology table algorithm cardiology checklist chf disease druginduced
Algorithm for the Treatment of Uremic Pruritus Nonpharmacologic Treatments: • Daily topical emollient • Avoidance of extremes
Algorithm for the Treatment ... Nonpharmacologic Treatments ... Evidence-Based Off-Label Pharmacologic ... Treatments of Uremic ... nalfurafine 2.5 mcg
Back to the "10 Need to Know" series - Drug Therapeutic Target Levels. For lithium, target
vary depending on treatment ... (0.5 - 0.8 ng/mL ... Ranges #Toxicology #Pharmacology
CNS Infection in HIV / AIDS - Differential Diagnosis Framework Principles of HIV-Associated CNS Opportunistic Infections: •
in HIV / AIDS - Differential ... : • Most CNS opportunistic ... • CNS opportunistic ... Antimicrobial treatment ... CNS #Infections #differential
Hyperviscosity Syndrome - Causes and Treatment - Waldenstrom macroglobulinemia (most common) / Plasmapheresis - Multiple
Syndrome - Causes and Treatment ... transformation (CML ... Syndrome #Causes #Differential ... #Diagnosis #Treatment
Mechanisms of Drug-Induced Hyperkalemia • Direct renin inhibitor (Aliskiren) • Renin release inhibition (NSAIDs, Beta-Blockers)
• Exogenous (KCL ... #hyperkalemia #differential ... pathophysiology #pharmacology
IDSA Recommendations for Preventing and Treating Penicillium marneffei Infections in HIV-AIDS Preventing 1st Episode of Penicilliosis (Primary
100 cells/mm3 g/mL ... IDSA #Prevention #Treatment ... #management #opportunistic ... infections #HIVAIDS #pharmacology
IDSA Recommendations for Treating Mucosal Candidiasis in HIV-AIDS Oropharyngeal Candidiasis: Initial Episodes (Duration of Therapy: 7–14 days) Preferred
suspension 4–6 mL ... for effective treatment ... IDSA #Prevention #Treatment ... #management #opportunistic ... infections #HIVAIDS #pharmacology
Choice of anticoagulant for treatment of pulmonary embolism • Malignancy - LMWH • To avoid parenteral
anticoagulant for treatment ... clearance <30 mL ... anticoagulation #pharmacology
IDSA Recommendations for Preventing and Treating Bacterial Enteric Infections in HIV-AIDS Preventing Bacterial Enteric Illness: • Antimicrobial
if MIC<0.12 ug/ml ... IDSA #Prevention #Treatment ... #management #opportunistic ... infections #HIVAIDS #pharmacology
IDSA Recommendations for Preventing and Treating Chagas Disease (American Trypanosomiasis) in HIV-AIDS Preventing Clinical Disease Indication: Individuals
duration same as for treatment ... Disease Note: Treatment ... IDSA #Prevention #Treatment ... #management #opportunistic ... infections #HIVAIDS #pharmacology
No results found for "MCL pharmacology differential treatment opportunistic"
Try removing search terms or sorting by relevance
Or Upload an image for you and others searching for #MCL #pharmacology #differential #treatment #opportunistic